Pharmaceutical composition, kit, uses of a preparation and composition, and methods for treating bleeding episodes in a patient, to reduce clotting time in a patient, to intensify hemostasis in a patient to reduce the number of administrations. of clotting factor protein needed to halt bleeding and maintain hemostasis in a patient, to reduce the amount of administered clotting factor protein needed to stop bleeding and maintain hemostasis in a patient, to prolong the lysis time of the patient. clot in a patient, to increase clot resistance in a patient and to intensify fibrin clot formation in a patient

摘要

"PHARMACEUTICAL COMPOSITION, KIT, USES OF A PREPARATION, AND A COMPOSITION, AND METHODS TO DEAL WITH HEMORRAGY EPISODES IN A PATIENT, TO REDUCE COAGULATION TIME IN A PATIENT, TO INTENSIFY IN A HEMOSIU HEMOSIU OF COAGULATION FACTOR PROTEIN ADMINISTRATIONS NECESSARY TO DETERMINE HEMORRAGY AND MAINTAIN HEMOSTASIA IN A PATIENT, TO REDUCE THE QUANTITATION OF PROTEIN COAGULATION FACTOR NEEDED TO HAVE HEMOSTERIA AND HEMOSTASIA LISING OF COAGLE IN A PATIENT, TO INCREASE COAGULES RESISTANCE IN A PATIENT AND TO INCREASE FIBRIN COAGLE FORMATION IN A PATIENT ". The invention relates to a pharmaceutical preparation comprising a factor VII-related or VH factor polypeptide and a factor VIII-related or factor VIII polypeptide. The invention also relates to the use of a factor VII-related or factor VII polypeptide and a factor VIII-related or factor VIII polypeptide for the manufacture of a medicament for pharmaceutical use, as well as methods for the prevention or treatment of bleeding episodes in patients.